Zivo Bioscience (ZIVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,385 | -7,777 | -8,745 | -8,756 | -9,106 |
| Depreciation Amortization | 98 | -171 | -694 | -534 | 1 |
| Accounts receivable | 2 | -4 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -424 | 675 | -164 | -905 | 187 |
| Other Working Capital | -501 | 1,281 | -355 | -394 | 2,669 |
| Other Operating Activity | 9,896 | 196 | 2,856 | 3,786 | 3,661 |
| Operating Cash Flow | $-4,314 | $-5,800 | $-7,103 | $-6,803 | $-2,588 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 518 | 1,756 | 629 | 191 | 251 |
| Debt Repayment | -21 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 5,602 | 4,275 | N/A | 17,265 | 2,130 |
| Other Financing Activity | -518 | -1,756 | -629 | -1,888 | 0 |
| Financing Cash Flow | $5,582 | $4,275 | $0 | $15,567 | $2,380 |
| Beginning Cash Position | 274 | 1,799 | 8,902 | 138 | 346 |
| End Cash Position | 1,542 | 274 | 1,799 | 8,902 | 138 |
| Net Cash Flow | $1,268 | $-1,525 | $-7,103 | $8,764 | $-208 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,314 | -5,800 | -7,103 | -6,803 | -2,588 |
| Free Cash Flow | -4,314 | -5,800 | -7,103 | -6,803 | -2,588 |